Lisinopril

   
Google
 
Web NewDrugInformation.com

Lisinopril


Drug - Lisinopril
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lisinopril
Multiple ingredients are in alphabetical order.

Strength - 20MG
The potency of the active ingredient(s), Lisinopril. May repeat for multiple part products.

Applicant - PUREPAC PHARM
The firm name holding legal responsibility for Lisinopril. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076164
The FDA assigned number to Lisinopril. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lisinopril. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 1, 2002
The date Lisinopril was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lisinopril. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lisinopril is in. Format is RX, OTC, DISCN.

Applicant Full Name - Purepac Pharmaceutical Co
The full name of the firm holding legal responsibility for the new application of Lisinopril.

Lisinopril